ABOS
Price
$1.03
Change
+$0.03 (+3.00%)
Updated
Jun 3, 04:08 PM (EDT)
Capitalization
61.78M
76 days until earnings call
CRBU
Price
$1.02
Change
+$0.05 (+5.15%)
Updated
Jun 3, 04:14 PM (EDT)
Capitalization
90.67M
70 days until earnings call
Interact to see
Advertisement

ABOS vs CRBU

Header iconABOS vs CRBU Comparison
Open Charts ABOS vs CRBUBanner chart's image
Acumen Pharmaceuticals
Price$1.03
Change+$0.03 (+3.00%)
Volume$100
Capitalization61.78M
Caribou Biosciences
Price$1.02
Change+$0.05 (+5.15%)
Volume$100
Capitalization90.67M
ABOS vs CRBU Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. CRBU commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Buy and CRBU is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2025
Stock price -- (ABOS: $1.00 vs. CRBU: $0.97)
Brand notoriety: ABOS and CRBU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 49% vs. CRBU: 230%
Market capitalization -- ABOS: $61.78M vs. CRBU: $90.67M
ABOS [@Biotechnology] is valued at $61.78M. CRBU’s [@Biotechnology] market capitalization is $90.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileCRBU’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • CRBU’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBU is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 1 TA indicator(s) are bullish while CRBU’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 1 bullish, 4 bearish.
  • CRBU’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а -1.96% price change this week, while CRBU (@Biotechnology) price change was -4.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.46%. For the same industry, the average monthly price growth was +5.51%, and the average quarterly price growth was +2.02%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

CRBU is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+8.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBU($90.7M) has a higher market cap than ABOS($61.8M). CRBU YTD gains are higher at: -38.686 vs. ABOS (-41.860). ABOS has higher annual earnings (EBITDA): -77.89M vs. CRBU (-159.14M). CRBU (208M) and ABOS (200M) have equal amount of cash in the bank . CRBU has less debt than ABOS: CRBU (26.2M) vs ABOS (28.5M). CRBU has higher revenues than ABOS: CRBU (9.92M) vs ABOS (0).
ABOSCRBUABOS / CRBU
Capitalization61.8M90.7M68%
EBITDA-77.89M-159.14M49%
Gain YTD-41.860-38.686108%
P/E RatioN/AN/A-
Revenue09.92M-
Total Cash200M208M96%
Total Debt28.5M26.2M109%
TECHNICAL ANALYSIS
Technical Analysis
ABOSCRBU
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 19 days ago
77%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NDBKY14.390.02
+0.10%
Nedbank Group, Ltd.
SSDOY15.98-0.07
-0.44%
Shiseido Company, Ltd.
DRPRY4.74-0.03
-0.63%
DR ING H C F PORSCHE AG
VLVLY27.20-0.59
-2.12%
Volvo AB
MRMD0.08-0.01
-9.76%
MariMed Inc.

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with FHTX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-1.96%
FHTX - ABOS
50%
Loosely correlated
+2.21%
BEAM - ABOS
49%
Loosely correlated
+2.27%
ALEC - ABOS
49%
Loosely correlated
+3.76%
ATOS - ABOS
49%
Loosely correlated
+11.54%
ABCL - ABOS
49%
Loosely correlated
+5.94%
More

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with FATE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-8.03%
FATE - CRBU
53%
Loosely correlated
+7.44%
CRSP - CRBU
53%
Loosely correlated
+1.82%
CCCC - CRBU
53%
Loosely correlated
+6.40%
AXON - CRBU
50%
Loosely correlated
+1.09%
BEAM - CRBU
50%
Loosely correlated
+2.27%
More